Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.
Viatris to Buy Pacira BioSciences for $1.65 Billion
Source: WSJ Technology
The Edge of the Cyber World See the latest
Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.
Source: WSJ Technology